Tha with the abg i prosthesis at 15 years: Excellent survival with minimal osteolysis

Clinical Orthopaedics and Related Research

Volumn 468, Issue 7, 2010, Pages 1855-1861

  Baker, P N ^a   McMurtry, I A ^a   Chuter, G ^a   Port, A ^a   Anderson, J ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; POLYETHYLENE; BIOMATERIAL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOPROSTHESIS LOOSENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL STRESS; OSTEOLYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTHESIS FAILURE; SURVIVAL RATE; TOTAL HIP PROSTHESIS; EQUIPMENT; FOLLOW UP; HIP ARTHROPLASTY; HIP PROSTHESIS; INSTRUMENTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSTHESIS; RADIOGRAPHY; REOPERATION; SURVIVAL;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; COATED MATERIALS, BIOCOMPATIBLE; DURAPATITE; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OSTEOLYSIS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REOPERATION; SURVIVAL ANALYSIS;

EID: 77954009264     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-009-1066-5     Document Type: Article

References (35)

1. Armitage P, Berry G. Statistical Methods in Medical Research. Ed 3. Oxford, UK: Blackwell Scientific Publications; 1994.
2. Blacha J. High osteolysis and revision rate with the hydroxyap- atite-coated ABG hip prostheses: 65 hips in 56 young patients followed for 5-9 years. Acta Orthop Scand. 2004; 75: 276-282.
3. Castoldi F, Rossi R, La Russa M, Sibelli P, Rossi P, Ranawat AS. Ten-year survivorship of the Anatomique Benoist Girard I total hip arthroplasty. J Arthroplasty. 2007; 22: 363-368.
4. D'Angelo F, Molina M, Riva G, Zatti G, Cherubino P. Failure of dual radius hydroxyapatite-coated acetabular cups. J Orthop Surg. 2008; 3: 35.
5. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br. 1996; 78: 185-190. (Pubitemid 26096988)
6. Dawson J, Fitzpatrick R, Murray D, Carr A. Comparison of measures to assess outcomes in total hip replacement surgery. Qual Health Care. 1996; 5: 81-88.
7. DeLee J, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res. 1976; 121: 20-32.
8. Duffy P, Sher JL, Partington PF. Premature wear and osteolysis in an HA-coated uncemented total hip arthroplasty. J Bone Joint Surg Br. 2004; 86: 34-38.
9. Epinette JA, Manley MT. Uncemented stems in hip replacement- hydroxyapatite or plain porous: does it matter? Based on a prospective study of HA Omnifit stems at 15-years minimum follow-up. Hip Int. 2008; 18: 69-74.
10. Eskelinen A, Remes V, Helenius I, Pulkkinen P, Nevalainen J, Paavolainen P. Uncemented total hip arthroplasty for primary osteoarthritis in young patients: a mid- to long-term follow-up study from the Finnish Arthroplasty Register. Acta Orthop. 2006; 77: 57-70.
11. Fitzpatrick R, Morris R, Hajat S, Reeves B, Murray DW, Hannen D, Rigge M, Williams O, Gregg P. The value of short and simple measures to assess outcomes for patients of total hip replacement surgery. Qual Health Care. 2000; 9: 146-150.
12. Giannikas KA, Din R, Sadiq S, Dunningham TH. Medium-term results of the ABG total hip arthroplasty in young patients. J Arthroplasty. 2002; 17: 184-188.
13. Gruen TA, McNiece GM, Amstutz HC. "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979; 141: 17-27.
14. Hallan G, Lie SA, Furnes O, Engesaeter LB, Vollset SE, Havelin LI. Medium- and long-term performance of 11,516 uncemented primary femoral stems from the Norwegian arthroplasty register. J Bone Joint Surg Br. 2007; 89: 1574-1580.
15. Harcourt WG, White SH, Jones P. Specificity of the Oxford knee status questionnaire: the effect of disease of the hip or lumbar spine on patients' perception of knee disability. J Bone Joint Surg Br. 2001; 83: 345-347.
16. Herrera A, Canales V, Anderson J, Garcia-Araujo C, Murcia- Mazoon A, Tonino AJ. Seven to 10 years follow-up of an anatomic hip prosthesis: an international study. Clin Orthop Relat Res. 2004; 423: 129-137.
17. Kim WY, Muddu BN. Eleven-year results of the ABG I hip replacement. Int Orthop. 2006; 30(3): 182-184.
18. Lewthwaite SC, Squires B, Gie GA, Timperley AJ, Ling RS. The Exeter Universal hip in patients 50 years or younger at 10-17 years' followup. Clin Orthop Relat Res. 2008; 466: 324-331.
19. Makela KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip arthroplasty for primary osteoarthritis in patients fifty- five years of age or older: an analysis of the Finnish arthroplasty registr. J Bone Joint Surg Am. 2008; 90: 2160-2170.
20. McKellop H, Shen FW, Lu B, Campbell P, Salovey R. Effect of sterilization method and other modifications on the wear resistance of acetabular cups made of ultra-high molecular polyethylene: a hip simulator study. J Bone Joint Surg Am. 2000; 82: 1708-1725.
21. Murray DW, Britton AR, Bulstrode CJ. Loss to follow-up matters. J Bone Joint Surg Br. 1997; 79: 254-257.
22. Murray DW, Carr AJ, Bulstrode C. Survival analysis of joint replacement. J Bone Joint Surg Br. 1993; 75: 697-704.
23. Nieuwenhuis JJ, Malefijt Jde W, Hendricks JC, Gosens T, Bonnet M. Unsatisfactory results with the cementless Omnifit acetabular component due to polyethylene and severe osteolysis. Acta Or- thop Belg. 2005; 71: 294-302.
24. Oosterbos CJ, Rahmy AI, Tonino AJ, Witpeerd W. High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years. Acta Orthop Scand. 2004; 75: 127-133.
25. Rajaratnam SS, Jack C, Tavakkolizadeh A, George MD, Fletcher RJ, Hankins M, Shepperd JA. Long-term results of a hydroxyapatite-coated femoral component in total hip replacement: a 15 to 21 year follow-up study. J Bone Joint Surg Br. 2008; 90: 27-30.
26. Reikeras O, Gunderson RB. Long-term results of HA coated threaded versus HA coated hemispheric press fit cups: 287 hips followed for 11 to 16 years. Arch Orthop Trauma Surg. 2006; 126: 503-508.
27. Rogers A, Kulkarni R, Downes EM. The ABG hydroxyapatite- coated hip prosthesis: one hundred consecutive operations with average 6-year follow-up. J Arthroplasty. 2003; 18: 619-625.
28. Rokkum M, Reigstad A. Polyethylene wear with an entirely HA- coated total hip replacement: 79 hips followed for 5 years. Acta Orthop Scand. 1998; 69: 253-258.
29. Rothman KJ. Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis. 1978; 31: 557-560.
30. Shetty AA, Slack R, Tindall A, James KD, Rand C. Results of a hydroxyapatite coated (Furlong) total hip replacement: a 13-15 year follow-up. J Bone Joint Surg Br. 2005; 87: 1050-1054.
31. Sutula LC, Collier JP, Saum KA, Currier BH, Currier JH, Sanford WM, Mayor MB, Wooding RE, Sperling DK, Williams IR, et al. The Otto Aufranc Award. Impact of gamma sterilization on clinical performance of polyethylene in the hip. Clin Orthop Relat Res. 1995; 319: 28-40.
32. Tannast M, Langlotz U, Siebenrock KA, Wiese M, Bernsmann K, Langlotz F. Anatomic referencing of cup orientation in total hip arthroplasty. Clin Orthop Relat Res. 2005; 436: 144-150.
33. Tonino AJ, Rahmy AI. The hydroxyapatite-ABG system: 5 to 7 year results from an international multicentre study. The International ABG Study Group. J Arthroplasty. 2000; 15: 274- 282.
34. Tonino AJ, Romanini L, Rossi P, Borroni M, Greco F, Garcia- Araujo C, Garcia-Dihinx L, Murcia-Maz(in A, Hein W, Anderson J. Hydroxyapatite-coated hip prostheses: early results from an international study. Clin Orthop Relat Res. 1995; 312: 211-215.
35. Wylde V, Learmonth ID, Cavendish VJ. The Oxford hip score: the patient's perspective. Health Qual Life Outcomes. 2005; 3: 66.